Online Database of Chemicals from Around the World 产品搜索 | 产品提交 | 产品推广 |

网站主页 >> 化工产品目录 >> Mirogabalin>> 市场分析报告
 

Mirogabalin市场分析报告

Pain Management- New Discoveries and Treatment Options in Abuse Deterrent Era
... stage NCE pipeline drugs (Cebranopadol, Mirogabalin, NKT-181, AVP-923,…) and ...

PharmaPoint: Painful Diabetic Neuropathy - Global Drug Forecast and Market Analysis to 2026
... to be ViroMed’s VM202 and Daiichi-Sankyo’s mirogabalin besylate, which both address some ...

Fibromyalgia - Pipeline Review, H1 2018
Fibromyalgia - Pipeline Review, H1 2018 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibromyalgia - Pipeline Review, H1 2018, provides an overview of the Fibromyalgia (Central Nervous System) pipeline ...

Fibromyalgia Therapeutics: Market Research Report
This report analyzes the Global market for Fibromyalgia Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for this market. Market data and analytics are ...

Therapeutic Class Overview: Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain
Pain is the leading cause of disability in the US, affecting more than cancer, diabetes and heart disease combined. Current analgesics for persistent pain are relatively ineffective, are associated with significant adverse effects or abuse liability, and ...

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain
Pain is the leading cause of disability in the US, affecting more than cancer, diabetes and heart disease combined. Current analgesics for persistent pain are relatively ineffective, are associated with significant adverse effects or abuse liability, and ...

Japan Pharma Outlook 2016: JP Giants leaning in for becoming a Speciality Global Pharma
... late stage pipeline/new launch, Mirogabalin approval in Neuropathic Pain, Brintellix Cognition ...

Fibromyalgia Global Clinical Trials Review, H2, 2017
Fibromyalgia Global Clinical Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Fibromyalgia Global Clinical Trials Review, H2, 2017' provides an overview of Fibromyalgia clinical trials scenario. This report provides top line data ...

Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017' provides an overview of Diabetic Peripheral Neuropathy clinical ...

Daiichi Sankyo Co Ltd (4568) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs ...




Copyright ©  chemBlink. 版权所有. 免责声明 | 网站简介 | 在线联系